AVEO Pharmaceuticals (AVEO) Tops Q1 EPS by 4c
Tweet
Share
E-mailGet Alerts AVEO Hot Sheet
Join SI Premium – FREE
AVEO Pharmaceuticals (NASDAQ: AVEO) reported Q1 EPS of ($0.21), $0.04 better than the analyst estimate of ($0.25).
For earnings history and earnings-related data on AVEO Pharmaceuticals (AVEO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Pulmatrix (PULM) Reports Q2 Loss of $0.29
- Ackman adds Netflix, Visa and Mastercard in portfolio revamp
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
